Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PLRXPLRX
25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PLIANT THERAPEUTICS INC

CITADEL ADVISORS LLC holds 2.1M shares of PLRX (PLIANT THERAPEUTICS INC), worth $2.4M as of 2026-Q2. The position was decreased (-33.6% shares). PLRX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.4M

Current Shares

2.1M

Total Value Change

-$37.6M

Total Shares Change

+909,446

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.1M
-33.6%
$2.4M0.0%$1.14
0
2026-Q1
Increased
3.2M
+24.9%
$4.1M0.0%$1.25
33
2025-Q4
Increased
2.6M
+10.4%
$3.2M0.0%$1.21
29
2025-Q3
Decreased
2.3M
-0.7%
$3.5M0.0%$1.49
0
2025-Q2
Increased
2.4M
+36.2Kx
$2.7M0.0%$1.25
42
2025-Q1
Decreased
65
-100.0%
$880.0%$1.47
0
2024-Q4
Increased
401,689
+1045.9%
$5.3M0.0%$12.79
44
2024-Q3
Decreased
35,054
-91.9%
$392,9550.0%$11.31
0
2024-Q2
Decreased
430,712
-74.7%
$4.6M0.0%$10.75
0
2024-Q1
Increased
1.7M
+7.8%
$25.4M0.0%$14.90
31
2023-Q4
Increased
1.6M
+3.8%
$28.6M0.0%$18.11
30
2023-Q3
Decreased
1.5M
-5.8%
$26.4M0.0%$17.34
0
2023-Q2
Increased
1.6M
+44.7%
$29.2M0.0%$18.26
39
2023-Q1
Increased
1.1M
+12.5%
$29.7M0.0%$26.54
32
2022-Q4
Increased
991,121
+137.2%
$19.2M0.0%$19.33
46
2022-Q3
Decreased
417,888
-69.8%
$8.7M0.0%$20.76
0
2022-Q2
Increased
1.4M
+0.4%
$11.1M0.0%$7.68
28
2022-Q1
Increased
1.4M
+3.0%
$9.7M0.0%$7.08
28
2021-Q4
Increased
1.3M
+0.7%
$18.1M0.0%$13.74
28
2021-Q3
Increased
1.3M
+10.8%
$22.4M0.0%$16.48
32
2021-Q2
Decreased
1.2M
-1.9%
$34.9M0.0%$28.20
0
2021-Q1
Decreased
1.2M
-0.8%
$48.1M0.0%$36.99
0
2020-Q4
Increased
1.2M
+0.2%
$28M0.0%$23.33
29
2020-Q3
Decreased
1.2M
-0.3%
$27.8M0.0%$23.74
0
2020-Q2
New
1.2M
-
$40M0.0%$35.26
40

Other major holders of PLRX: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used